US Broker Ratings

Sanofi (SNY) Stock Analysis: Unveiling a 24% Upside Amid Robust Dividend Yield

Sanofi (NASDAQ: SNY), a pharmaceutical giant headquartered in Paris, France, continues to capture investor interest with its promising potential upside and robust dividend yield. The company, a leader in the..

Waters Corporation (WAT) Stock Analysis: Insights into a Healthcare Giant with a 9.56% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specializes in diagnostics and research technology, particularly in the realms of liquid chromatography and mass spectrometry. Headquartered in Milford,..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a Promising 11.58% Upside Potential

AbbVie Inc. (NYSE: ABBV), a powerhouse in the healthcare sector, is capturing investor attention with its robust market presence and compelling growth prospects. As a leading player in the drug..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Its 0.76% Upside Potential Amid Strong Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, is a leading player in the drug manufacturing industry with a market capitalization of $188.67 billion. Known for its extensive..

CVS Health Corporation (CVS) Stock Analysis: A 7.41% Potential Upside with Strong Analyst Support

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is capturing investor attention with its robust market presence and potential upside. With a market capitalization of $122.4 billion..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 12% Potential Upside Amid Robust Free Cash Flow and Strong Dividend Yield

Pfizer Inc. (NYSE: PFE), a titan in the healthcare sector, continues to attract investor attention with its robust market presence and a portfolio of biopharmaceutical products that cater to a..

Edwards Lifesciences Corporation (EW) Stock Analysis: 12.75% Potential Upside with Robust Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW) stands out in the healthcare sector, particularly within the medical devices industry, as a leader in cardiovascular disease treatment technologies. With a formidable market capitalization..

Thermo Fisher Scientific (TMO) Investor Outlook: Assessing a 27% Potential Upside Amidst Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is drawing considerable attention from investors due to its robust..

Abbott Laboratories (ABT) Investor Outlook: Harnessing a 28.79% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a favorite among investors for its stability and innovation. With a market capitalization of $158.63 billion, Abbott..

Cytokinetics, Inc. (CYTK) Stock Analysis: Exploring a 36.40% Potential Upside in the Biotechnology Sector

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing attention with its ambitious focus on developing innovative treatments targeting muscle-related diseases. With a market capitalization of..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 23% Potential Upside in the Biotech Arena

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a pivotal player in the biotechnology industry, with a strong focus on the development of RNA-targeted therapeutics and gene therapy for rare diseases...

BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is capturing investor attention with its robust revenue growth and strategic positioning in the Health Information Services industry...

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating Zero Upside but Strong Cash Flow

As Soleno Therapeutics, Inc. (NASDAQ: SLNO) continues to make strides in the healthcare sector, particularly within the biotechnology industry, investors are taking a closer look at its financial and performance..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside

In the rapidly evolving healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves with its innovative approach to treating obstructive sleep apnea (OSA). The company’s flagship product, the..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook Reveals 56% Potential Upside Amid Robust Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its compelling potential upside of 56.48%, driven by its innovative approach in the biotechnology sector. As a commercial-stage biopharmaceutical company,..

Glaukos Corporation (GKOS) Stock Analysis: Unpacking a 49.49% Potential Upside in the Medical Devices Sector

Investors seeking opportunities within the healthcare sector should take a closer look at Glaukos Corporation (NYSE: GKOS), a notable player in the medical devices industry. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Riding the Wave of a 57% Potential Upside

For investors with an eye on the healthcare sector, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents a compelling opportunity. Specializing in digital healthcare, iRhythm is at the forefront of integrating technology..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Promising 112% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) presents a compelling opportunity for investors with its innovative approach in the biotechnology sector. Specializing in vaccine development, this clinical-stage company is on the forefront of..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 38% Upside Potential Despite Recent Challenges

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, has been a staple in the plasma-derived medicines market for over a century. Headquartered in Barcelona, Spain, Grifols..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds